share_log

Avalo Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven Boyd(4.99%),Armistice Capital, LLC(4.7%)

SEC announcement ·  Jun 28, 2023 06:02
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.